ClinicalTrials.Veeva

Menu

The Asian Transcatheter Aortic Valve Replacement Registry (Asian TAVR)

S

Seung-Jung Park

Status

Completed

Conditions

Aortic Valve Stenosis
Aortic Diseases

Treatments

Device: transcatheter aortic valve replacement

Study type

Observational

Funder types

Other

Identifiers

NCT02308150
AMCCV2014-14

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in the Asian Pacific population

Full description

This registry changes to TP-TAVR registry(NCT03826264). Some subjects moved to TP-TAVR registry and continue to 10-year follow-up.

Enrollment

1,505 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site

Trial contacts and locations

12

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems